- Home
- IOVA vs PMT Comparison
IOVA vs PMT Comparison
Compare IOVA & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- PMT
- Stock Information
- Founded
- IOVA 2007
- PMT 2009
- Country
- IOVA United States
- PMT United States
- Employees
- IOVA N/A
- PMT N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- PMT Real Estate Investment Trusts
- Sector
- IOVA Health Care
- PMT Real Estate
- Exchange
- IOVA Nasdaq
- PMT Nasdaq
- Market Cap
- IOVA 975.1M
- PMT 1.1B
- IPO Year
- IOVA N/A
- PMT 2009
- Fundamental
- Price
- IOVA $1.83
- PMT $12.19
- Analyst Decision
- IOVA Buy
- PMT Hold
- Analyst Count
- IOVA 11
- PMT 5
- Target Price
- IOVA $10.80
- PMT $14.13
- AVG Volume (30 Days)
- IOVA 14.8M
- PMT 1.0M
- Earning Date
- IOVA 11-06-2025
- PMT 10-21-2025
- Dividend Yield
- IOVA N/A
- PMT 13.14%
- EPS Growth
- IOVA N/A
- PMT N/A
- EPS
- IOVA N/A
- PMT 0.92
- Revenue
- IOVA $241,525,000.00
- PMT $564,655,000.00
- Revenue This Year
- IOVA $68.14
- PMT N/A
- Revenue Next Year
- IOVA $56.64
- PMT $27.87
- P/E Ratio
- IOVA N/A
- PMT $13.28
- Revenue Growth
- IOVA 636.99
- PMT N/A
- 52 Week Low
- IOVA $1.64
- PMT $11.60
- 52 Week High
- IOVA $12.51
- PMT $14.93
- Technical
- Relative Strength Index (RSI)
- IOVA 34.71
- PMT 49.33
- Support Level
- IOVA $1.94
- PMT $11.82
- Resistance Level
- IOVA $2.20
- PMT $12.76
- Average True Range (ATR)
- IOVA 0.14
- PMT 0.28
- MACD
- IOVA -0.04
- PMT -0.01
- Stochastic Oscillator
- IOVA 3.31
- PMT 50.64
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through three segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.